Clinical trials
Phase 1 Lymphoma, B-Cell, Marginal Zone trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Eli Lilly and Company | 1 |
| Epizyme, Inc. | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
| Nurix Therapeutics, Inc. | 1 |
| Prelude Therapeutics | 1 |
| Xencor, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 8 |
| Lymphoma, Mantle-Cell | 8 |
| Lymphoma, Follicular | 7 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Waldenstrom Macroglobulinemia | 5 |
| Lymphoma, Non-Hodgkin | 3 |
| Recurrence | 3 |
| Hematologic Neoplasms | 2 |
| Lymphoma, B-Cell | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.